Login / Signup

A Nationwide Study on the Incidence of Breast Cancer in Korean Women with Osteoporosis Receiving Raloxifene Treatment.

Jihyoun LeeJi Sung LeeJong Eun LeeSung-Won KimSun Wook HanSung-Mo HurYoung Jin ChoiSungmin Park
Published in: Journal of breast cancer (2021)
Long-term treatment with raloxifene in women with osteoporosis was not significantly associated with a reduction in breast cancer rates. However, further investigation is required for a conclusive proof.
Keyphrases
  • postmenopausal women
  • bone mineral density
  • risk factors
  • body composition
  • replacement therapy
  • smoking cessation
  • breast cancer risk